Paper Details

  1. Home
  2. Paper Details

Alopecia induced by lopinavir plus ritonavir therapy in an HIV patient.

Author: ChrysosGeorge, KokkorisStelios, KontochristopoulosGeorge, MikrosSotirios, PastelliAndroula

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Lopinavir/ritonavir, an antiretroviral medication used to treat HIV infection, is associated with several side effects. This report describes a case of alopecia totalis (complete hair loss) in a 62-year-old man who was treated with lopinavir/ritonavir. The alopecia resolved when the patient was switched to nelfinavir.
Paper Details　
Original Abstract of the Article :
The most commonly reported side effects related to lopinavir/ritonavir are diarrhea, vomiting, headache, nausea, and increased serum triglycerides and cholesterol levels. About 4% of the patients prescribed lopinavir/ritonavir stop taking it because of side effects. Alopecia, generally involving the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/17763601

データ提供：米国国立医学図書館（NLM）

Alopecia Induced by Lopinavir Plus Ritonavir Therapy: A Unexpected Side Effect

In the vast desert of HIV treatment research, we are constantly searching for effective and safe therapies to manage this complex condition. This study, exploring the field of infectious diseases, reports a case of alopecia totalis, a complete loss of hair, in a patient with HIV who was taking the antiretroviral drugs lopinavir and ritonavir.

Imagine a desert with a lone traveler experiencing a sudden and unexpected sandstorm, representing the hair loss experienced by the HIV patient. The researchers investigated the potential link between the patient's medication regimen and their alopecia. They carefully reviewed the patient's medical history and drug interactions. They found that the alopecia resolved after the patient switched from lopinavir/ritonavir to nelfinavir, suggesting that the former medication may have been responsible for the hair loss.

A Rare Side Effect: Alopecia and Antiretroviral Therapy

This study reports a rare side effect of lopinavir/ritonavir therapy, alopecia totalis. While alopecia is not a common side effect of this medication, it's important to be aware of this potential complication, especially for patients with HIV who are taking lopinavir/ritonavir.

Navigating the Desert of HIV Treatment: Monitoring for Side Effects

HIV treatment is often a long and challenging journey. This study highlights the importance of closely monitoring patients for potential side effects, including those that may not be common. Consulting with a healthcare professional is essential to discuss any concerns or changes in health status.

Dr.Camel's Conclusion

The desert of HIV treatment research is vast and ever-evolving. This study reminds us that we must be vigilant in monitoring for potential side effects of medications, even those that are considered rare. Remember, staying informed and seeking professional guidance is essential for navigating the complexities of HIV treatment.

Date :
  1. Date Completed 2007-09-25
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

17763601

DOI: Digital Object Identifier

17763601

Related Literature

Article Analysis
・Side Effects of nelfinavir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.